 SAN FRANCISCO, April 12, 2021 PRNewswire -- Schubert Jonckheer Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Merit Medical Systems, Inc. NASDAQ: MMSI relating to possible false statements to investors and insider trading by officers and directors. A securities class action against the company in the United States District Court for the Central District of California recently survived a motion to dismiss allegations that between February 26 and October 30, 2019, Merit and its CEO and CFO made false and misleading statements about the companys integration of Cianna and ClariVein, two highly-touted corporate acquisitions. 